Hi guys, PBT is my maiden Biotech stock, so excuse my inexperience in this question!
The fact that we have met our 100-patient target, and are looking at possibly adding more numbers, is this "the norm"? I mean, why do we need to put more people on the trial?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $128.9M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $141.9K | 10.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 4178039 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 5033034 | 20 |
View Market Depth
| Last trade - 13.31pm 23/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |